#VisualAbstract: Expectant management of patent ductus arteriosus in extremely premature infants was non-inferior to early ibuprofen treatment
Click here to read this study in NEJM
Tag: bronchopulmonary dysplasia (BPD)
Laryngeal mask airway is suitable method for surfactant administration in infants with respiratory distress syndrome
1. In a randomized controlled trial, laryngeal mask airway (LMA) surfactant administration was associated with lower rates of early failure ...
Organizational factors increase risk of unplanned extubation in neonatal intensive care unit
1. In a retrospective study, higher nursing overtime hours and rate, and increased number of patients supported by mechanical ventilation ...
Quality improvement initiative improves use of ventilator alarms amongst children with chronic respiratory failure
1. Using a stepwise, interdisciplinary approach, an algorithm was developed to improve the rates of safety alarms set on ventilators ...
Hydrocortisone does not improve bronchopulmonary dysplasia outcomes in pre-term babies
1. In extremely preterm infants on mechanical ventilation, hydrocortisone was unable to improve 36-week survival or 2-year survival without neurodevelopmental ...
#VisualAbstract: Enteral water-soluble vitamin A in extremely preterm infants does not reduce severity of bronchopulmonary dysplasia
1. Daily enteral water-soluble vitamin A in extremely preterm infants did not significantly reduce the severity of BPD compared to ...
Enteral water-soluble vitamin A does not reduce bronchopulmonary dysplasia severity in extremely preterm infants
1. Daily enteral water-soluble vitamin A in extremely preterm infants did not significantly reduce the severity of BPD compared to ...
Increased survival without major morbidity noted among very low birthweight infants in California
1. In a retrospective cohort study of almost 50 000 very low birth weight infants (VLBW), overall survival without major ...
Hydrocortisone in very preterm infants does not improve rates of bronchopulmonary dysplasia and mortality
1. There were no significant differences in rates of bronchopulmonary dysplasia (BPD) and mortality at 36 weeks’ postmenstrual age (PMA) ...